Prime Venture, Leo Capital back biotech startup StrainX in $13M round
Prime Venture Partners and Leo Capital lead investment as the IIT Delhi-founded startup bets on precision fermentation and bio-manufacturing for global markets.
Search fresh public links, source activity, and post angles for Biotech Startup.
Fresh curated links around biotech startup are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Prime Venture Partners and Leo Capital lead investment as the IIT Delhi-founded startup bets on precision fermentation and bio-manufacturing for global markets.
Duracyte’s implants employ cells engineered to produce therapeutic protein, bypassing the complexities of traditional biologics manufacturing. The startup’s marriage of biotechnolo...
Bengaluru and Delaware-based LiteFold is a biotech AI-native platform designed to accelerate computational biology workflows.
Isomorphic Labs’ Series B financing is the second largest ever raised by a biotech startup. Like the largest one, Isomorphic is also opaque about its drug programs. The post This...
10x Science has raised a $4.8 million seed round to help pharmaceutical researchers understand complex molecules.
India’s largest biotech startup competition returns with Rs 20 crore prize pool, widening push to back science-led innovation beyond metro hubs.
Founded by Tristan Bepler PhD ’20 and former MIT professor Tim Lu PhD ’07, OpenProtein.AI offers researchers open-source models and other tools for protein engineering.
Californian protein sequencing company Alamar Biosciences is seeking an IPO worth up to $159 million amid a growing boom in life sciences public offerings.
The Luxembourg-founded startup is already in production with multiple top-20 global pharma companies, including a public collaboration with Pfizer. Its $10M seed round is led by re...
It’s no secret that finding success in the biotech industry can be extraordinarily challenging. With long timeframes (the discovery to The post 4 Mistakes Biotech Startups Make — A...
Anthropic has acquired Coefficient Bio, a stealth biotech AI startup founded barely eight months ago, in an all-stock deal worth just over $400 million. The acquisition brings a te...
Banyan BioInnovations is debuting with more than $100 million aimed at developing NewCos around promising clinical assets, plus a partnership with global contract research organiza...
Anthropic has purchased the stealth biotech AI startup Coefficient Bio in a $400 million stock deal, according to The Information and Eric Newcomer.
In the sprawling metropolis of Houston, a new biotech has emerged to tackle the biology underlying a lung disease that has no clear cause. Oorja Bio launched yesterday afternoon wi...
Parabilis is teeing up the latest high-profile stock issuance in a year when biotech IPOs are averaging more than $286 million in total proceeds.
The Series B round was led by Battery Ventures.
A quantum tech firm that has collaborated with—and received investment from—Amgen is now planning to go public.
The companies Earendil Labs, Teva Pharmaceuticals, and Solid Biosciences bagged the biggest biotech funding rounds overall in March 2026. The post The biggest biotech funding round...
The Paris techbio company screens microbial genomes to find molecules that evolution spent three billion years producing, and claims to have characterised more novel small molecule...
The biotechnology startup emerged from stealth with a peptide drug it claims to have the potential to reverse lung scarring in people with idiopathic pulmonary fibrosis.
Fragrance tech company Patina announced Thursday a $2 million raise from investors, including Betaworks and True Ventures.
Young biotechs usually get acquired instead of profitably selling their own medicines. A growing number are proving they can, which could make the sector more broadly appealing to...
The former leaders of SpringWorks Therapeutics are back with a new biotech venture that is already buzzing from a $300 million series A.
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.